Literature DB >> 990309

Aminopeptidase activities on the surface of mammalian cells.

T Aoyagi, H Suda, M Nagai, K Ogawa, J Suzuki.   

Abstract

Activities of hydrolytic enzymes on the surface of monkey kidney, canine kidney, L. FM3A and various tumor cells were determined and compared with those in the cell homogenate. Although aminopeptidase (EC 3.4.11.-) activities were always detected on the surface membrane in mammalian cells, trypsin, chymotrypsin and elastase activities were not detected while slight glycosidase activity was detected in a suspension of cultured cells. The activities of alanine-, leucine-, methionine- and phenylalanine-aminopeptidases were rather high but aminopeptidase A, proline-, valine-, glycyl propline dipeptidyl-and glycyl propyl leucine-tripeptidyl-aminopeptidases showed relatively low activities. Aminopeptidase activity was also demonstrated in the isolated membrane fractions. The specific activities of enzymes in these membrane fractions were not significantly greater than in cell homogenate so it was concluded that these enzyme activities were rather loosely bound to the cell membrane. Further evidence for the localization of the aminopeptidase activities on the cell surface was obtained by using glass-bead-bound substrate and detecting the release of the terminal residues. When bestatin, a specific inhibitor against aminopeptidase B and leucine aminopeptidase, was included in the assay system for the enzyme activities on the cell surface, the enzymes were commonly inhibited in all types of cells.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 990309     DOI: 10.1016/0005-2744(76)90064-4

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

1.  Antibody-induced linkages of plasma membrane proteins to intracellular actomyosin-containing filaments in cultured fibroblasts.

Authors:  J F Ash; D Louvard; S J Singer
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

2.  Pharmacokinetics of bestatin and oral activity for treatment of experimental metastases.

Authors:  F Abe; G Alvord; M Koyama; A Matsuda; J E Talmadge
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

3.  Various enzyme activities in muscle and other organs of dystrophic mice.

Authors:  T Aoyagi; T Wada; F Kojima; M Nagai; H Umezawa
Journal:  J Clin Invest       Date:  1981-01       Impact factor: 14.808

4.  Restoration of E-rosette formation by bestatin in patients with bladder cancer.

Authors:  H Yokoyama; T Umeda; K Kobayashi; H Akaza; T Niijima
Journal:  J Cancer Res Clin Oncol       Date:  1980       Impact factor: 4.553

5.  Stimulation of cell-mediated immunity by bestatin correlates with reduction of bacterial persistence in experimental chronic Salmonella typhimurium infection.

Authors:  G Dickneite; F Kaspereit; H H Sedlacek
Journal:  Infect Immun       Date:  1984-04       Impact factor: 3.441

6.  Ubenimex activates the E-cadherin-mediated adhesion of a breast cancer cell line YMB-S.

Authors:  S Fujioka; N Kohno; K Hiwada
Journal:  Jpn J Cancer Res       Date:  1995-04

7.  Inhibitory effect of the oral immune response modifier, bestatin, on cell-mediated and cell-free HIV infection in vitro.

Authors:  A S Bourinbaiar; S Lee-Huang; K Krasinski; W Borkowsky
Journal:  Biomed Pharmacother       Date:  1994       Impact factor: 6.529

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.